Cmh Wealth Management LLC Abb Vie Inc. Transaction History

Cmh Wealth Management LLC

$405 Million
Q2 2024

A detailed history of Cmh Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cmh Wealth Management LLC holds 2,254 shares of ABBV stock, worth $437,907. This represents 0.1% of its overall portfolio holdings.

Number of Shares

2,254

Holding current value

$437,907

% of portfolio

0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$154.79 - $180.76 $348,896 - $407,433	2,254 New	2,254 $386,000
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $1.9 Million - $2.54 Million	-25,838 Closed	0 $0
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $404,544 - $613,338	6,272 Added 32.06%	25,838 $1.97 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $159,046 - $199,001	2,205 Added 12.7%	19,566 $1.73 Million
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $137,989 - $165,902	-2,191 Reduced 11.21%	17,361 $1.32 Million
Q2 2019 Jul 15, 2019	BUY	$65.7 - $83.98 $3,022 - $3,863	46 Added 0.24%	19,552 $1.42 Million
Q1 2019 Apr 15, 2019	SELL	$77.14 - $90.79 $1.09 Million - $1.28 Million	-14,095 Reduced 41.95%	19,506 $1.57 Million
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $70,065 - $86,409	900 Added 2.75%	33,601 $3.1 Million
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $239,612 - $266,373	2,695 Added 8.98%	32,701 $3.11 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $381,205 - $451,052	4,246 Added 16.48%	30,006 $2.79 Million
Q1 2018 Apr 11, 2018	BUY	$92.01 - $123.21 $6,900 - $9,240	75 Added 0.29%	25,760 $2.36 Million
Q4 2017 Jan 12, 2018	BUY	$89.56 - $98.21 $2,686 - $2,946	30 Added 0.12%	25,685 $2.53 Million
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $1.79 Million - $2.29 Million	25,655	25,655 $2.32 Million

Others Institutions Holding ABBV

# of Institutions

3,699

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cmh Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cmh Wealth Management LLC with notifications on news.

Account

Cmh Wealth Management LLC Abb Vie Inc. Transaction History